Is AN2 Therapeutics, Inc. (ANTX) a Buy, Sell, or Hold?
AN2 Therapeutics, Inc.
NASDAQ:ANTX
$4.67 USD
-$0.09 (-1.89%)
- Volume
- 108.82K
- Average Volume
- 325.4K
- Market Capitalization
- $127.97M
- P/E Ratio
- -4.25
- Dividend Yield
- 0.00%
- Price Target
- $9.00
- Year High
- $6.91
- Year Low
- $1.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.73
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-48.1% DOWNSIDE
$9.00 Price Target
UPSIDE/DOWNSIDE HIGH
-48.1% DOWNSIDE
$9.00 Price Target High
UPSIDE/DOWNSIDE LOW
-48.1% DOWNSIDE
$9.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Leerink Partners | Joseph Schwartz | $9 | $4.31 | 2026-05-14 06:05 AM | 108.8% |
| JMP Securities | Roy Buchanan | $2 | $1.2 | 2025-05-05 05:15 AM | 66.7% |
| Leerink Partners | Joseph Schwartz | $5 | $2.13 | 2024-07-03 02:12 AM | 134.7% |
| Evercore ISI | Liisa Bayko | $2 | $2.27 | 2024-05-16 12:41 AM | -11.9% |
| JMP Securities | Roy Buchanan | $6 | $3.76 | 2024-04-01 10:23 PM | 59.6% |